Quick Summary

Pau d’Arco (Handroanthus impetiginosus) is a tree native to Central and South America traditionally used in folk medicine. Current scientific literature primarily focuses on its botanical, ecological, and molecular biology aspects rather than robust clinical evidence supporting medicinal benefits. Limited preclinical studies indicate potential antimicrobial and antiparasitic activities linked to compounds such as β-lapachone found in related species. However, human clinical trials investigating the efficacy, safety, adverse effects, and drug interactions of Pau d’Arco or its extracts are lacking.

What Is It?

Pau d’Arco refers to the inner bark of Handroanthus impetiginosus, a tree native to tropical regions of Central and South America. The plant belongs to the Bignoniaceae family and has been traditionally harvested for its reputed medicinal properties.

Traditional Uses

  • General traditional medicinal use in folk medicine across its native range.
  • Reported uses include treatment for various infections and general health support, although these claims are not substantiated by rigorous clinical research.

Active Compounds

Key bioactive constituents thought to contribute to Pau d’Arco’s effects include:

  • β-Lapachone – a naphthoquinone compound found in related species, associated with antimicrobial and antiparasitic activities in preclinical studies.

Potential Benefits with Evidence Levels

  • Antiparasitic activity against Giardia duodenalis (Preclinical, Level 3 evidence):
    In vitro studies using extracts of closely related species (e.g., Tabebuia avellanedae) and β-lapachone demonstrated selective antigiardial effects, with β-lapachone showing lower inhibitory concentrations than metronidazole. These studies utilized human gastrointestinal epithelial models derived from organoids and reported no cytotoxicity with hydroalcoholic extracts. However, no direct studies on Pau d’Arco itself or clinical trials have been conducted.

Side Effects

Currently, there are no documented adverse effects specifically associated with Pau d’Arco in humans. No systematic data or meta-analyses are available to describe side effect profiles.

Drug Interactions

No clinical evidence exists regarding potential drug interactions involving Pau d’Arco or its chemical constituents.

Who Should Avoid It

  • Due to the lack of safety data, pregnant or breastfeeding individuals should avoid Pau d’Arco as no information on safety or precautions is available.
  • People with underlying health conditions or those taking medications should consult healthcare providers before use, considering the absence of interaction data.
  • No evidence-based contraindications have been identified, but caution is advised due to limited information.

Evidence Limitations

  • Lack of human clinical trials or randomized controlled trials specifically investigating Pau d’Arco.
  • Existing studies focus mainly on in vitro or preclinical research using related species or isolated compounds.
  • No systematic reviews or meta-analyses summarizing human efficacy or safety are available.
  • Traditional uses have not been confirmed by rigorous clinical studies.
  • Clinical safety, tolerability, dosing guidelines, and potential interactions remain uncharacterized.

References

Last Reviewed

June 2024

Informational Disclaimer: This herb database page is for educational purposes only and does not provide medical advice. The information presented here does not substitute for professional consultation with healthcare practitioners. Always consult a qualified healthcare provider before using herbal products, especially if you have underlying health conditions, are pregnant or breastfeeding, or are taking medications.